AI could help doctors pick better diabetes drugs
NCT ID NCT07684690
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study tests whether an artificial intelligence (AI) tool can help doctors choose better diabetes medicines for patients with type 2 diabetes. Many patients are treated by doctors who are not diabetes specialists, so the AI provides real-time suggestions and predictions about which medications might work best. Patients with poorly controlled blood sugar are randomly assigned to have their doctor use the AI tool or prescribe as usual. The study follows patients for 12 months to see if the AI leads to better blood sugar control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AI-assisted antidiabetic drug consultation system
- What this could lead to
- If successful, this AI tool could help non-specialist doctors prescribe more effective diabetes medications, leading to better blood sugar control for many patients.
- What could go wrong
- The AI only provides suggestions, and doctors may not follow them. The study is relatively small and results may not apply to all populations or healthcare settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital
Taipei, 100, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Student pharmacists may hold the key to better diabetes control in older asian adults
- Can a blood vessel drug beat aspirin at preventing heart attacks in diabetes?
- New Dual-Action drug aims to tackle fatty liver where semaglutide falls short
- Can a 12-Week exercise program boost brain and body health in older adults with diabetes?
- Diabetes drugs may shield against severe pneumonia outcomes
- Saliva test could spot hidden links between diabetes and gum disease